544
Participants
Start Date
March 25, 2024
Primary Completion Date
December 1, 2027
Study Completion Date
March 31, 2028
Switching to a different medication
Participants will receive four weeks of the other FDA approved option, either varenicline or combination NRT, with instructions to try to quit again at week 4.
Continued use of the same medication
Participants will receive four additional weeks of the same medication (varenicline or NRT) with instructions to try to quit again at week 4.
Switching to a harm reduction tobacco product
Participants will receive four weeks of e-cigarette products with instructions to switch completely at Week 8
RECRUITING
Medical University of South Carolina, Charleston
National Cancer Institute (NCI)
NIH
Medical University of South Carolina
OTHER